Leigh Wilhelmina A
Ethics Behav. 1998;8(4):305-19. doi: 10.1207/s15327019eb0804_4.
This article explores the ethical concerns and protections that may be required when individually identifiable data originally collected solely for clinical or administrative purposes are used in research or evaluation. It asks the following broad question with respect to the interim policy developed by the Substance Abuse and Mental Health Services Administration (SAMHSA) to protect the rights and welfare of participants in its programs: For those programs and projects not classified as research, are the protections and system for review adequate? Background information on SAMHSA's interim policy is provided, along with issues and questions related to the use of clinical and administrative records in research and evaluation. The article concludes with recommendations for modifying the existing participant protection guidelines, based on the preceding discussion of issues and questions.
本文探讨了最初仅为临床或管理目的收集的可识别个人身份的数据用于研究或评估时可能需要的伦理考量和保护措施。它针对药物滥用和精神健康服务管理局(SAMHSA)制定的旨在保护其项目参与者权利和福利的临时政策提出了以下宽泛问题:对于那些未被归类为研究的项目和计划,其保护措施和审查系统是否足够?文中提供了关于SAMHSA临时政策的背景信息,以及与研究和评估中使用临床和管理记录相关的问题。基于前文对问题的讨论,本文最后给出了修改现有参与者保护指南的建议。